News & Updates

Antihypertensive therapy (AHT) may be used safely during the COVID-19 pandemic, as no evidence suggest that it can increase the risk of SARS-CoV-2 infection or death, according to a UK study. In addition, most classes of antihypertensives are negatively associated with COVID-19 diagnosis.

Use of cardiovascular medications does not lead to poor COVID-19 clinical outcomes among high-risk patients, such as those with hypertension, according to a study.

Vaccines against SARS-CoV-2 has a safety profile that is similar in patients with inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD) and those with noninflammatory RMD (NI-RMD), according to a study. The vaccines are well tolerated with rare reports of I-RMD flare and serious adverse events.

Use of 5α-reductase inhibitors (5ARIs) appears to lower the risk of community-acquired infection with SARS-CoV-2 in men without prostate cancer, according to a study, noting that treatment with this drug class can help ease the burden of COVID-19.

The coronavirus disease 2019 (COVID-19) pandemic has led to a sharp decline in treatment for older patients with newly diagnosed cancers of the digestive system, a recent study has found.

Diabetes mellitus (DM) raises the risk of mortality and respiratory failure, as well as the need for intensive care, among patients with the coronavirus disease 2019 (COVID-19), reports a recent Philippine study.

There was an increase in the incidence of dry-eye disease (DED) during the lockdown for the coronavirus disease 2019 (COVID-19), a recent study has found. Such a spike may be related to the increase in use of visual display terminals (VDTs).

Both individualized counselling (IC) and pamphlets have improved the uptake of influenza vaccination, but IC does not appear to be superior to pamphlets alone at improving vaccine acceptance, according to a Singapore study.